These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19416749)

  • 1. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.
    Chang J; Jallouli Y; Kroubi M; Yuan XB; Feng W; Kang CS; Pu PY; Betbeder D
    Int J Pharm; 2009 Sep; 379(2):285-92. PubMed ID: 19416749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
    Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
    Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
    Jallouli Y; Paillard A; Chang J; Sevin E; Betbeder D
    Int J Pharm; 2007 Nov; 344(1-2):103-9. PubMed ID: 17651930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
    Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
    Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders.
    Carroll RT; Bhatia D; Geldenhuys W; Bhatia R; Miladore N; Bishayee A; Sutariya V
    J Drug Target; 2010 Nov; 18(9):665-74. PubMed ID: 20158436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R; Zhu J; Yang X; Xu H
    J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.
    Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A
    J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY; Feng SS
    Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW; Wang SS; Tsai WJ
    Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Lin PI; Wang CC
    Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
    Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
    Lalani J; Rathi M; Lalan M; Misra A
    Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
    Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
    Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loading efficiency and surface conductance of heparin-modified poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Shih KH
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):282-7. PubMed ID: 19329287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study.
    Wang SS; Chou NK; Chung TW
    J Biomed Mater Res A; 2009 Dec; 91(3):753-61. PubMed ID: 19051299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.